News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • NAND-driven gains highlight rising AI storage demand, benefiting storage suppliers.
  • Western Digital shows strong free cash flow and shrinking net debt while gaining cloud and AI customer revenue.
  • Trade idea: go long WDC to capture pricing leverage, using a tight stop for valuation risk.
  • Wolfspeed offers asymmetric upside from silicon carbide adoption across EVs, fast charging, and data centers.
  • Recommended Wolfspeed trade: disciplined long with a defined entry, protective stop, and a $40 target.
  • Semiconductor materials and AI storage themes could prompt near-term rotation into tech hardware stocks.

Latest Articles

BJ's Restaurants: Appetite for More After a Strong Breakout

BJ's Restaurants: Appetite for More After a Strong Breakout

BJ's Restaurants (BJRI) has ripped to fresh 52-week highs on heavy volume, but the move is backed by solid profitability, healthy free cash flow and a conservative balance sheet. The stock looks actionable on a mid-term (45 trading days) swing with a clear entry, stop and target that balances momentum with valuation discipline.

MKDWELL Tech Inc. to Acquire Premium Smart-Home and IoT Group, Diversifying Beyond Automotive Electronics

MKDWELL Tech Inc. to Acquire Premium Smart-Home and IoT Group, Diversifying Beyond Automotive Electronics

MKDWELL Tech Inc., listed on Nasdaq (MKDW), has announced the acquisition of Landvision Inc., a developer of AI-enabled smart-home and IoT products. This acquisition will diversify MKDWELL's business from automotive electronics to the growing smart-home sector, leveraging complementary strengths in embedded electronics and manufacturing. The deal i…

Erasca (ERAS): A Buy at the Backdoor to RAS Inhibitor Competition

Erasca (ERAS): A Buy at the Backdoor to RAS Inhibitor Competition

Erasca has the science, a modality-agnostic RAS/MAPK pipeline and fresh capital. Recent legal and clinical setbacks pushed sentiment into the gutter; that creates a trading opportunity for investors willing to take event risk. This trade targets a mid-term recovery if the company executes on clinical updates and the patent dispute does not derail d…

XPO: Leaner LTL, AI Gains, and a Trade for Patient Long-Term Returns

XPO: Leaner LTL, AI Gains, and a Trade for Patient Long-Term Returns

XPO's operational rebound in North American LTL, durable free cash flow, and visible AI-driven productivity gains make it a constructive long-term trade. Valuation is not cheap, but the combination of improving operating ratios, a $456M free cash flow run-rate and bullish technicals supports a long entry at current levels for a 180-trading-day hori…

WISeKey Files Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission in Connection with Proposed Redomiciliation to the British Virgin Islands

WISeKey Files Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission in Connection with Proposed Redomiciliation to the British Virgin Islands

WISeKey International Holding Ltd filed a Form F-4 registration statement with the U.S. SEC to facilitate its proposed redomiciliation from Switzerland to the British Virgin Islands through a merger between WISeKey and its wholly owned subsidiary WISeKey BVI. The merger will result in WISeKey BVI becoming the publicly traded parent company. The tra…

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

Zentalis Pharmaceuticals announced two upcoming presentations at the ESMO Congress 2026 highlighting the overall survival results from their DENALI Part 1b study of azenosertib, a first-in-class WEE1 inhibitor targeting Cyclin E1-positive platinum-resistant ovarian cancer. The data supports ongoing late-stage clinical development and regulatory str…

Royalty Pharma declares third quarter 2026 dividend

Royalty Pharma declares third quarter 2026 dividend

Royalty Pharma plc declared a dividend of $0.235 per Class A ordinary share for the third quarter of 2026, payable on September 10, 2026, to shareholders of record as of August 14, 2026. The company remains a leading acquirer and funder within the biopharmaceutical royalties sector, with a diverse portfolio of royalties on top-selling and developme…

VALUE LINE, INC. DECLARES  A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAM

VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAM

Value Line, Inc. announced a quarterly cash dividend of $0.35 per share payable in August 2026 and approved a renewal of its stock repurchase program with up to $2 million authorized. The company emphasizes its confidence in its shares and continues to offer extensive investment research services to individual and institutional investors.

Immuneering Corporation Announces Grants of Inducement Awards

Immuneering Corporation Announces Grants of Inducement Awards

Immuneering Corporation announced the granting of inducement stock option awards to its newly appointed Chief Financial Officer, Andrew Gengos, and a non-executive employee. The options are part of the company's 2025 Employment Inducement Award Plan and are intended to incentivize service and align interests with shareholders. The company is focuse…

Hingham Reports Second Quarter 2026 Results

Hingham Reports Second Quarter 2026 Results

Hingham Institution for Savings reported strong second quarter 2026 results, with net income of $25.4 million, representing a 168.5% increase over the prior year quarter. Core net income also grew by 42.2%. The bank saw modest asset growth, strong deposit increases particularly in low-cost non-interest bearing deposits, and improved net interest ma…

Agencia Comercial Spirits Ltd Announces Entry into Construction, Network Infrastructure and Maintenance Agreements for Indonesia AI Computing Deployment

Agencia Comercial Spirits Ltd Announces Entry into Construction, Network Infrastructure and Maintenance Agreements for Indonesia AI Computing Deployment

Agencia Comercial Spirits Ltd, a Taiwan-based whisky importer and distributor listed on NASDAQ, announced that its subsidiaries have entered into contracts for the construction of a data center, procurement of network infrastructure, and a five-year technical support and maintenance agreement to support its planned AI computing infrastructure expan…

Trump urges Darline Graham to enter South Carolina Senate special primary

Trump urges Darline Graham to enter South Carolina Senate special primary

On July 17 President Donald Trump said he had asked Darline Graham, sister of the late Senator Lindsey Graham, to run in the Republican special primary in South Carolina scheduled for August 11. Trump posted on Truth Social that he hopes she will run and that she would have his endorsement. The sister was appointed by South Carolina Governor Henry …

UFC Names Meridianbet Official Partner of Fight Night Belgrade

UFC Names Meridianbet Official Partner of Fight Night Belgrade

Meridian Holdings Inc.'s subsidiary Meridianbet has been named the official partner and exclusive sports-betting sponsor for UFC Fight Night Serbia, scheduled for August 1, 2026. This event marks the UFC's debut in Serbia and represents a major branding opportunity for Meridianbet, a leader in online sports betting with operations across Europe, Af…

Buy Merck Ahead of Lipfendra Milestone and Continued Oncology Rollouts

Buy Merck Ahead of Lipfendra Milestone and Continued Oncology Rollouts

Merck (MRK) is a Strong Buy on expectation of a near-term regulatory milestone for its new oncology candidate Lipfendra and continued commercialization of its oncology portfolio. The stock offers a compelling mix of steady cash generation (free cash flow $14.1B), a $315B market cap, and an established commercial engine. We lay out a clear entry, st…

Q2 Holdings: Oversold Fintech, Favorable Risk/Reward for a Long Rebound

Q2 Holdings: Oversold Fintech, Favorable Risk/Reward for a Long Rebound

<p>Q2 Holdings' share-price damage feels overstated relative to its fundamentals. The company has moved customers to the cloud, is producing positive free cash flow, and still grows revenue double digits — yet the stock trades nearer its 52-week low than its highs. This trade idea lays out a concrete long entry, stop and target with a clear 180-tra…